Following the departure of one analyst, we terminate the coverage with recommendation of the following issuers: Advanz Pharma, CBR Fashion Group, Ceconomy, Cheplapharm, Eurofins, Grenke, Grünenthal, IHO/Schaeffler, Ontex, Profine, Progroup, Stada, Teleperformance, Wepa and ZF Friedrichshafen. We intend to gradually resume coverage of some of these companies. Previous credit opinions and market recommendations are listed in the table on page 2.
Following the departure of one analyst, we terminate the coverage with recommendation of the following issuers: Advanz Pharma, CBR Fashion Group, Ceconomy, Cheplapharm, Eurofins, Grenke, Grünenthal, IHO/Schaeffler, Ontex, Profine, Progroup, Stada, Teleperformance, Wepa and ZF Friedrichshafen. We intend to gradually resume coverage of some of these companies. Previous credit opinions and market recommendations are listed in the table on page 2.
Celanese: CFR downgraded by S&P, with the outlook still negative|Eroski announces refinancing plan including new offering of 2031 notes|Altice International: exclusive talks for the sale of Hot Mobile for NIS 2.1bn (€ 561m)|Crédit Agricole S.A. unveils its strategic plan ACT 2028|
Celanese: CFR downgraded by S&P, with the outlook still negative|Eroski annonce un plan de refinancement comportant une nouvelle émission obligataire 2031|Altice International : négociations exclusives pour la vente de Hot Mobile pour 2,1 mds NIS (561 m EUR)|Crédit Agricole présente ce matin son nouveau plan stratégique 2028|
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.